A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
People living with lupus develop strengths that are unique to this journey, and it’s time we paused to honor and celebrate the strengths of a lupus warrior.
National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
If you have a parent, sibling, or child diagnosed with lupus — but you do not have lupus yourself — you may be eligible to participate in CARE Lupus. Lupus has long been treated after symptoms begin - ...
The Next Chapter in Lupus Care: Phase III & FDA Fast Track Clinical Trials, Therapies & What’s Ahead
This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results